Newborn affected by maternal exposure to environmental chemical substances
ICD-10 P04.6 is a billable code used to indicate a diagnosis of newborn affected by maternal exposure to environmental chemical substances.
P04.6 refers to newborns who are affected by maternal exposure to environmental chemical substances, particularly noxious substances transmitted via the placenta or breast milk. This includes exposure to drugs, alcohol, and tobacco during pregnancy or lactation. Maternal drug use can lead to a range of neonatal complications, including withdrawal symptoms, growth restrictions, and developmental delays. Alcohol exposure can result in fetal alcohol spectrum disorders, characterized by physical, behavioral, and cognitive impairments. Tobacco exposure is associated with low birth weight, preterm birth, and respiratory issues in newborns. Accurate coding requires thorough documentation of maternal history, substance use patterns, and any resultant neonatal complications. The clinical management of these newborns often involves a multidisciplinary approach, including neonatologists, pediatricians, and social services, to address both immediate health concerns and long-term developmental needs.
Detailed maternal history, including substance use, prenatal care records, and neonatal assessment findings.
Newborns presenting with withdrawal symptoms, low birth weight, or developmental delays due to maternal substance exposure.
Consideration of the timing and amount of exposure, as well as the need for interdisciplinary care.
Comprehensive developmental assessments and follow-up care plans for affected newborns.
Pediatric evaluations for developmental delays or behavioral issues stemming from prenatal exposure.
Long-term monitoring for potential developmental and behavioral issues.
Used when a newborn affected by maternal substance exposure requires initial evaluation.
Document maternal history, neonatal assessment findings, and any interventions performed.
Neonatologists should focus on withdrawal management and developmental assessments.
Documentation should include a detailed maternal history of substance use, prenatal care records, and a thorough neonatal assessment that outlines any complications or symptoms related to the exposure.
